Dr. James Austin Fountain, PHARM.D. Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 2631 16th St, Bedford, IN 47421 Phone: 812-275-7134 Fax: 812-275-7205 |
Timothy O'rourke Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 629 Lincoln Ave, Bedford, IN 47421 Phone: 812-277-1702 |
Brian Scott Darnell Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 3200 John Williams Blvd, Bedford, IN 47421 Phone: 812-275-0415 Fax: 812-275-0375 |
Ms. Lauren Selo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 16th St, Bedford, IN 47421 Phone: 812-277-9375 |
Rebecca L Jones, RPH, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 3200 John Williams Blvd, Bedford, IN 47421 Phone: 812-275-0415 |
Tracy Blyeth Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 3200 John Williams Blvd, Bedford, IN 47421 Phone: 812-275-0415 Fax: 812-275-0375 |
Jeanne Lager, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 16th St, Bedford, IN 47421 Phone: 812-277-9375 |
Michelle Lynn Goldsberry, RPH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 3200 John Williams Blvd, Bedford, IN 47421 Phone: 812-275-0415 Fax: 812-275-0375 |
Dr. Rich Schmitt, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1206 16th St, Bedford, IN 47421 Phone: 812-275-3393 |
Lynn Greene Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1206 16th St, Bedford, IN 47421 Phone: 812-275-3393 Fax: 812-275-8164 |
Mr. James Edward Schroeder I, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 16th St, Bedford, IN 47421 Phone: 812-277-9375 Fax: 812-277-9458 |
Logan Richard Fiscus, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 16th St, Bedford, IN 47421 Phone: 812-890-3372 |
Hoon Chae Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1206 16th St, Bedford, IN 47421 Phone: 812-275-3393 |
Laura Cummings Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 2631 16th St, Bedford, IN 47421 Phone: 812-275-8167 |
Jade Schuckman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2412 16th St, Bedford, IN 47421 Phone: 812-275-3383 |
Dr. Hope Nett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 23rd St, Bedford, IN 47421 Phone: 812-276-1280 |
Emily Hicks, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 2900 16th St, Bedford, IN 47421 Phone: 812-278-8800 |
Cathy Frances Deringer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3200 John Williams Blvd, Bedford, IN 47421 Phone: 812-275-0415 |
Mr. Steven Mark Anderson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 631 16th St, Bedford, IN 47421 Phone: 812-275-5949 |
Zachary Geyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2412 16th St, Bedford, IN 47421 Phone: 812-275-3383 |
News Archive
A new preprint discusses the pathogenesis of this critical COVID-19 with reference to autoimmune phenomena involving the key antiviral type I interferon pathway.
According to a report issued last week by UNAIDS, access to antiretroviral therapy is beginning to reduce AIDS mortality worldwide.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.
Vanda Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee voted overwhelmingly to recommend the approval of Vanda's New Drug Application for tasimelteon, proposed tradename HETLIOZ™, for the treatment of Non-24-Hour Disorder (Non-24) in the totally blind.
› Verified 1 days ago